Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis

Published:2021-09 Issue: Volume: Page:
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Oykhman Paul,Paramo Fernando Aleman,Bousquet Jean,Kennedy David W.,Brignardello-Petersen Romina,Chu Derek K.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Quality of life in patients with chronic rhinosinusitis;Rudmik;Curr Allergy Asthma Rep,2011

2. Burden of illness: a systematic review of depression in chronic rhinosinusitis;Schlosser;Am J Rhinol Allergy,2016

3. Prevalence of nasal polyps in adults: the Skovde population-based study;Johansson;Ann Otol Rhinol Laryngol,2003

4. Prevalence of nasal polyposis in France: a cross-sectional, case–control study;Klossek;Allergy,2005

5. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis;Chen;Curr Med Res Opin,2020

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics;Respiratory Medicine;2024-11

2. Comparative safety of monoclonal antibodies in chronic inflammatory airway diseases (chronic sinusitis with nasal polyposis and asthma): A network meta-analysis;International Immunopharmacology;2024-09

3. Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-08-26

4. Is the United Kingdom (UK) medicines pricing policy failing patients? The impact of terminated National Institute for Health and Care Excellence (NICE) appraisals for multi-indication products on patients;2024-08-07

5. Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study;Asia Pacific Allergy;2024-08